Sha's Organic Skincare and MedSpa
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
- Laser Therapy (LLLT)
- Acne Treatment
Silver Spring, MD
Silver Spring sits in Montgomery County on the DC border, home to a dense concentration of federal workers at agencies like the FDA, Discovery Communications' headquarters, and a substantial East African immigrant community, particularly Ethiopian and Eritrean. The local IV therapy market serves a professionally and culturally diverse demographic, with clinics clustered along Georgia Avenue, East-West Highway, and near Holy Cross Hospital. Maryland Board of Nursing rules allow RNs to place peripheral IVs under physician delegation, and Maryland NPs gained full practice authority under Senate Bill 723. DC metro summer humidity drives hydration demand, and the high density of FDA and NIH professionals supports a patient base that asks informed questions about protocol design and pharmacy sourcing. Mobile service is common into Takoma Park, Wheaton, and Bethesda.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Maryland medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.